A Comparison of hs-CRP Levels in New Diabetes Groups Diagnosed Based on FPG, 2-hPG, or HbA1c Criteria

Table 3

hs-CRP levels in women and men with newly detected DM using the FPG, 2-hPG, or HbA1c criteria.

Diagnostic methods	hs-CRP; mg/L [nmol/L]
	Women		Men
	Mean (SEM), ()	95% CI	Mean (SEM), ()	95% CI
FPG-DM; ( = 477)	3.3 (0.1), ( = 309); 31.5 (1.3)]	3.0–3.5; 28.6–33.6]	2.5 (0.2) ( = 168); 23.4 (1.6)]	2.13–2.80; 20.3–26.6]
2-hPG-DM; ( = 653)	3.2 (0.1) ( = 483); 30.5 (1.0)]	3.0–3.40; 28.5–32.4]	3.0 (0.2) ( = 170); 29.0 (1.6)]	2.7–3.4; 25.9–32.1]
HbA1c-DM; ( = 597)	4.0 (0.1) ( = 356); 38.5 (1.2)]	3.8–4.3; 36.2–40.8]	3.1 (0.1) ( = 241); 29.8 (1.3)]	2.9–3.40; 27.2–32.4]
Post hoc comparisons	FPG-DM versus 2-hPG-DM, = 0.698		FPG-DM versus 2-hPG-DM, = 0.017
	FPG-DM versus HbA1c-DM, = 0.000032		FPG-DM versus HbA1c-DM, = 0.003
	2-hPG-DM versus HbA1c-DM, < 0.000001		2-hPG-DM versus HbA1c-DM, = 0.0695

Adjusted for age, BMI, waist, and hypertension (HT). Women: ; men: .